Madrigal Pharmaceuticals (MDGL) Rises After Successful New-Drug Launch and Strong Execution
Madrigal Pharmaceuticals rallied after a strong new-drug launch and effective commercial execution, prompting analyst upgrades and lifting near-term revenue expectations.
Yahoo Finance
2 min read
Stocks
Market Analysis
Biotech